Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone

Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone

Mycobacterium ulcerans is the causal agent of Buruli ulcer, a chronic infectious disease and the third most common mycobacterial disease worldwide. Without early treatment, M. ulcerans provokes massive skin ulcers, caused by the mycolactone toxin, its main virulence factor. However, spontaneous heal...

Full description

Bibliographic Details
Main Authors:	Marie Robbe-Saule, Mélanie Foulon, Isabelle Poncin, Lucille Esnault, Hugo Varet, Rachel Legendre, Alban Besnard, Anna E. Grzegorzewicz, Mary Jackson, Stéphane Canaan, Laurent Marsollier, Estelle Marion
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-12-01
Series:	Virulence
Subjects:	mycobacterium ulcerans host-bacterium interaction mycolactone rna-sequencing metabolism
Online Access:	http://dx.doi.org/10.1080/21505594.2021.1929749

Similar Items

The Mycobacterium ulcerans toxin mycolactone causes destructive Sec61-dependent loss of the endothelial glycocalyx and vessel basement membrane to drive skin necrosis
by: Louise Tzung-Harn Hsieh, et al.
Published: (2025-02-01)

Rate of Production of Inflammatory Cytokines TNF and IL- by Peripheral Blood Mononuclear Cells Stimulated with Mycolactone
by: P Mohajeri, et al.
Published: (2010-08-01)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
by: Katharina Röltgen, et al.
Published: (2020-05-01)

Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer
by: Gideon A. Akolgo, et al.
Published: (2023-07-01)

From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone
by: Daniela Ricci, et al.
Published: (2023-05-01)

Emergence and spread of Mycobacterium ulcerans at different geographic scales
by: Martial Briand, et al.
Published: (2024-04-01)

Variable Number Tandem Repeat Profiling of Mycobacterium ulcerans Reveals New Genotypes in Buruli Ulcer Endemic Communities in Ghana and Côte d’Ivoire
by: Elizabeth Gyamfi, et al.
Published: (2022-06-01)

Secondary bacterial isolates from previously untreated Buruli ulcer lesions and their antibiotic susceptibility patterns in Southern Nigeria
by: Moses Chibueze Anyim, et al.

Environmental Variations in Mycobacterium ulcerans Transcriptome: Absence of Mycolactone Expression in Suboptimal Environments
by: Daniel Sanhueza, et al.
Published: (2019-03-01)

IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection
by: Aloysius D. Loglo, et al.
Published: (2018-07-01)

Potential Animal Reservoir of Mycobacterium ulcerans: A Systematic Review
by: Avishek Singh, et al.
Published: (2018-05-01)

A case of guilt by association: Water bug bite incriminated in M. ulcerans infection
by: Estelle Marion, et al.
Published: (2014-01-01)

Mycobacterium ulcerans Treatment Costs, Australia
by: Christina Drummond, et al.
Published: (2004-06-01)

Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls
by: Marie-Line Reynaert, et al.
Published: (2019-09-01)

Risk Factors for Mycobacterium ulcerans Infection, Southeastern Australia
by: Tricia Y.J. Quek, et al.
Published: (2007-11-01)

Ongoing Genome Reduction in Mycobacterium ulcerans
by: Simona Rondini, et al.
Published: (2007-07-01)

High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice
by: Kirstie M. Mangas, et al.
Published: (2020-08-01)

Heterogeneity among Mycobacterium ulcerans Isolates from Africa
by: Pieter Stragier, et al.
Published: (2006-05-01)

Histopathologic Features of Mycobacterium ulcerans Infection
by: Jeannette Guarner, et al.
Published: (2003-06-01)

Snapshot fecal survey of domestic animals in rural Ghana for Mycobacterium ulcerans
by: Nicholas J. Tobias, et al.
Published: (2016-06-01)

Survey of local fauna from endemic areas of Northern Queensland, Australia for the presence of Mycobacterium ulcerans
by: Avishek Singh, et al.
Published: (2019-01-01)

Understanding the Significance of Biochemistry in the Storage, Handling, Purification, and Sampling of Amphiphilic Mycolactone
by: Jessica Z. Kubicek-Sutherland, et al.
Published: (2019-04-01)

Improved protocols for isolation of Mycobacterium ulcerans from clinical samples
by: Bernadette Agbavor, et al.
Published: (2025-03-01)

Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease
by: Louisa Warryn, et al.
Published: (2023-09-01)

Mycobacterium ulcerans disease
by: Tjip S. van der Werf, et al.

Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia
by: Alex Y.C. Tai, et al.
Published: (2018-01-01)

Multi-epitope vaccine candidates based on mycobacterial membrane protein large (MmpL) proteins against Mycobacterium ulcerans
by: Tamara Z. Ishwarlall, et al.
Published: (2023-11-01)

Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
by: Juan Dominguez, et al.
Published: (2023-09-01)

Mycobacterium ulcerans disease in the middle belt of Ghana: An eight-year review from six endemic districts
by: Emmanuel J.K Adu, et al.
Published: (2015-01-01)

PPE Barcoding Identifies Biclonal Mycobacterium ulcerans Buruli Ulcer, Côte d’Ivoire
by: B. G. O. Tchan, et al.
Published: (2023-06-01)

Mycobacterium ulcerans in Possum Feces before Emergence in Humans, Australia
by: Bridgette J. McNamara, et al.
Published: (2025-03-01)

Mycobacterium ulcerans Infection Imported from Australia to Missouri, USA, 2012
by: Benjamin Stuart Thomas, et al.
Published: (2014-11-01)

A Mycobacterium ulcerans vaccine pilot trial using an accurate low-dose challenge
by: Stephen Muhi, et al.
Published: (2024-08-01)

Exposure Risk for Infection and Lack of Human-to-Human Transmission of Mycobacterium ulcerans Disease, Australia
by: Daniel P. O’Brien, et al.
Published: (2017-05-01)

A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study. [version 1; peer review: 1 approved, 2 approved with reservations]
by: Stephen Muhi, et al.
Published: (2024-08-01)

A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study. [version 2; peer review: 1 approved, 2 approved with reservations]
by: Stephen Muhi, et al.
Published: (2024-10-01)

Recombinant Antibodies against Mycolactone
by: Leslie Naranjo, et al.
Published: (2019-06-01)

Regulation of mycolactone, the Mycobacterium ulcerans toxin, depends on nutrient source.
by: Caroline Deshayes, et al.
Published: (2013-11-01)

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone
by: Ok-Ryul Song, et al.
Published: (2017-07-01)

Serologic Response to Culture Filtrate Antigens of Mycobacterium ulcerans during Buruli Ulcer Disease
by: Karen M. Dobos, et al.
Published: (2000-04-01)